Peptide Name: BPC-157 (Body Protection Compound-157)
Molecular Formula: C62H98N16O22
Molecular Weight: ~1419.5 g/mol
Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Parent Peptide: Thymosin Beta-4 (Tβ4)
Molecular Formula: C212H350N56O78S
Molecular Weight: ~4963 g/mol
Compound Class: Synthetic peptide (Thymosin Beta-4)
Sequence: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser
In-vitro evaluation of multi-peptide compatibility and stability
Laboratory studies examining interactions between distinct peptide classes
Comparative analysis of single-peptide versus blended research systems
Analytical and mechanistic research involving synthetic regulatory peptides
Store in a cool, dry environment away from direct light
Maintain container tightly sealed when not in use
Handle using appropriate laboratory safety and aseptic techniques
Analytical Approach to Finished Formulations: Purity is a metric used for isolated raw materials, such as lyophilized peptide powders. Finished formulations—such as capsules, liquids, and topicals—contain multiple components, including excipients and stabilizers. In these systems, a single purity value does not accurately represent the overall composition. Instead, identity and assay (content) are reported on the COA to confirm the presence of the correct compound and to verify that the labeled amount per unit is accurate. This approach reflects standard analytical practice and provides more meaningful information for research applications.
Format: Encapsulated solid multi-peptide research blend
Appearance: White to off-white solid
Solubility: Soluble in aqueous laboratory media following capsule removal for analytical use